Host-Directed Therapy for Intracellular Bacteria via mROS Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rise of antibiotic-resistant bacteria, particularly Mycobacterium tuberculosis, poses a significant public health threat due to increased drug resistance, necessitating new strategies to enhance the host immune response rather than relying solely on pathogen-targeted approaches.
Innovation Solution
Administration of specific compounds such as Metformin, Resveratrol, and others to increase mitochondrial reactive oxygen species (mROS) generation and phagosome acidity, thereby enhancing the host's immune response to inhibit bacterial growth and infection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics or antibacterial agents are used to control bacterial growth, then bacterial infection is treated, but bacteria develop resistance to the antibiotics
Solution Approach 1:
Instead of targeting the bacteria directly with antibiotics, the patent inverts the approach by targeting the host cell's mitochondrial function to generate ROS that will kill the intracellular bacteria. This host-directed therapy bypasses the bacteria's ability to develop resistance to conventional antibiotics.
Solution Approach 2:
The patent introduces mitochondrial reactive oxygen species (mROS) as an intermediary mechanism to eliminate bacteria. The compounds administered do not directly kill bacteria but instead stimulate the host cell's mitochondria to produce ROS, which then act as the actual bactericidal agent, creating a new pathway that bacteria cannot easily resist.
2Reliability
If host immune response is enhanced to inhibit bacterial growth, then bacterial infection is controlled, but the complexity of the treatment mechanism increases
Solution Approach 1:
The patent enables the host cell's own mitochondria to serve the immune function by generating ROS in response to bacterial infection. The administered compounds act as triggers that activate the host's intrinsic defense mechanisms, rather than requiring complex external treatment systems.
Solution Approach 2:
The patent changes the physiological parameters of the host cell by modulating mitochondrial function and ROS production levels. By altering these biochemical parameters through compound administration, the host immune response is enhanced without requiring complex mechanical or structural interventions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds effectively inhibit intracellular bacterial growth by boosting the host's immune response, including significant reductions in Mycobacterium tuberculosis loads in both cellular and animal models, with Metformin showing dose-dependent inhibition and potential to enhance the efficacy of standard tuberculosis drugs.
Implementation Method 1
increasing mitrochondrial reactive oxygen species (mROS) generation to inhibit bacterial growth in a cell
Implementation Method 2
increasing the acidity of bacterial phagosomes to inhibit bacterial growth in a cell
Data Source
AI summary
Disclosed is a method of preventing, treating or inhibiting bacterial infections. The method comprises administering at least one of the compounds disclosed herein. Also disclosed are methods of increasing acidity of bacterial phagosomes to inhibit bacterial growth, methods of increasing mitochondrial reactive oxygen species (mROS) generation to inhibit bacterial growth in a cell, pharmaceutical compositions and uses thereof.